Evaluation of cardiovascular events in patients with hepatocellular carcinoma treated with sorafenib in the clinical practice. The Cardio-sor study

MLA

María Martín, et al. Evaluation of Cardiovascular Events in Patients with Hepatocellular Carcinoma Treated with Sorafenib in the Clinical Practice. The Cardio-Sor Study. Jan. 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....264789fbf96e9188ea4f782cc26507db&authtype=sso&custid=ns315887.

APA

María Martín, Andrés Castaño-García, María Luisa González-Diéguez, Maria Varela, Javier Cuevas, Rebeca Lorca, Carmen Álvarez-Navascués, Rut Álvarez-Velasco, Manuel Rodríguez, V. Cadahía, César Morís, & Lorena Carballo-Folgoso. (2021). Evaluation of cardiovascular events in patients with hepatocellular carcinoma treated with sorafenib in the clinical practice. The Cardio-sor study.

Chicago

María Martín, Andrés Castaño-García, María Luisa González-Diéguez, Maria Varela, Javier Cuevas, Rebeca Lorca, Carmen Álvarez-Navascués, et al. 2021. “Evaluation of Cardiovascular Events in Patients with Hepatocellular Carcinoma Treated with Sorafenib in the Clinical Practice. The Cardio-Sor Study,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....264789fbf96e9188ea4f782cc26507db&authtype=sso&custid=ns315887.